Skip to main content
. 2004 Jun;57(6):773–784. doi: 10.1111/j.1365-2125.2004.02073.x

Figure 2.

Figure 2

Mean plasma concentration profiles of fosfluconazole after intravenous injection of fosfluconazole in subjects with normal renal function (○), n = 6; mild renal impairment (▴), n = 7; moderate renal impairment (•), n = 6; and severe renal impairment (Δ), n = 6